Affiliation:
1. Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University
2. The Yeda Hospital of Yantai City
Abstract
Abstract
Objective
To explore the causal relationship between colorectal cancer risk and circulating cytokines and identify potential predictive biomarkers.
Methods
This study employed a bidirectional Mendelian randomization (MR) analysis based on data from genome-wide association (GWAS) studies of colorectal cancer from people of European ancestry. The genetic variants associated with 41 circulating cytokines exposed were selected as instrumental variables for this experiment. For robustness and consistency of findings, we conducted additional sensitivity analyses and reverse Mendelian randomization assessments.
Results
The analysis revealed a strong causal relationship between colorectal cancer occurrence and Vascular Endothelial Growth Factor (VEGF), Macrophage Colony Stimulating Factor (MCSF), Interleukin-12p70 (IL-12p70), Interleukin-13(IL-13), Interleukin-10 levels (IL-10) and Interleukin-7 levels (IL-7) and demonstrated partial consistency. Sensitivity analyses indicated that IL-12p70, IL-7 and VEGF are potential colorectal cancer predictive biomarkers.
Conclusion
This Mendelian randomized study offers valuable insights into the causal relationships between specific circulating cytokines and colorectal cancer risk. The identified cytokines may serve as predictive biomarkers, enabling the development of novel diagnostic, preventive, and therapeutic approaches, but further experimental validation of their potential as diagnostic biomarkers or cancer-related pharmacological targets is necessary.
Publisher
Research Square Platform LLC
Reference26 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021
2. Identification of a biomarker panel for colorectal cancer diagnosis;Garcé“a-Bilbao A;BMC Cancer,2012
3. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?;Hofman P;Ann Oncol,2019
4. Singh, R., M.K. Mishra and H. Aggarwal, Inflammation, Immunity, and Cancer. Mediators Inflamm, 2017. 2017: p. 6027305.
5. Why cancer and inflammation?;Rakoff-Nahoum S;Yale J Biol Med,2006